Daniel R. Passeri
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel R. Passeri
Daniel R. Passeri is recorded as CEO and Board Member at Cue Biopharma, Inc. (CUE). Cue Biopharma, Inc. reported in an 8-K filed June 10, 2025 that Daniel R. Passeri was appointed principal financial and accounting officer on an interim basis, effective June 13, 2025. The proxy statement of Cue Biopharma, Inc. reports total compensation of $1,426,183 for Daniel R. Passeri in fiscal 2025, including a base salary of $240,504. Disclosed compensation is on record for 8 fiscal years.
“Effective June 13, 2025, Daniel R. Passeri, the Company's Chief Executive Officer, will serve as the Company's principal financial and accounting officer on an interim basis until a new principal financial and accounting officer is designated.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cue Biopharma, Inc. (CUE)
SEC 8-K
Current2025-06-13–present
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cue Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Shao-Lee Lin CEO, Board Member
- Lucinda Warren CEO, CFO
- Usman Azam CEO, Board Member
- James Ahlers CFO
- Kerri Millar CFO
- Colin G. Sandercock General Counsel
- Sumita Ray General Counsel
- Michael Meluzio Chief Accounting Officer
- Daniel Camardo Board Member
- Jill Broadfoot Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cue Biopharma, Inc. (CUE) | Former Chief Executive Officer | $240,504 | $1,426,183 |
| 2024 | Cue Biopharma, Inc. (CUE) | Former Chief Executive Officer | $492,910 | $1,393,921 |
| 2023 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $604,824 | $3,015,480 |
| 2022 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $747,507 | $1,373,850 |
| 2021 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $530,974 | $1,820,756 |
| 2020 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $501,154 | $5,841,786 |
| 2019 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $395,000 | $1,198,614 |
| 2018 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $345,000 | $833,858 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.